{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:01:37Z","timestamp":1791543697408,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"am","delay-in-days":261,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857"],"award-info":[{"award-number":["ZIAMH002857"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH121959"],"award-info":[{"award-number":["MH121959"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH120876"],"award-info":[{"award-number":["MH120876"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH128771"],"award-info":[{"award-number":["MH128771"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["BX004758"],"award-info":[{"award-number":["BX004758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022290","name":"Institute for Research on Poverty","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbi.2025.03.009","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:58:40Z","timestamp":1741460320000},"page":"229-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Assessment of complement cascade components in patients with major depressive disorder"],"prefix":"10.1016","volume":"127","author":[{"given":"Brandi","family":"Quintanilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dede","family":"Greenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alona","family":"Bartosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anilkumar","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.03.009_b0005","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates IL-1\u03b2 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation","volume":"122","author":"Asgari","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbi.2025.03.009_b0010","article-title":"Prefrontal glutamate neurotransmission in PTSD: a novel approach to estimate synaptic strength in vivo in humans","volume":"11","author":"Averill","year":"2022","journal-title":"Chronic Stress (Thousand Oaks)."},{"key":"10.1016\/j.bbi.2025.03.009_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.bbi.2025.03.009_b0020","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.3390\/molecules27175502","article-title":"Exosome proteomics reveals the deregulation of coagulation, complement and lipid metabolism proteins in gestational diabetes mellitus","volume":"27","author":"Bernea","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbi.2025.03.009_b0025","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4049\/jimmunol.132.4.1967","article-title":"Functional studies on the secreted form of human C4 (C4s), two incompletely processed two-subunit C4 molecules (beta - alpha + gamma and beta + alpha - gamma), and pro-C4","volume":"132","author":"Chan","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2025.03.009_b0030","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.psyneuen.2012.11.007","article-title":"Sex differences in neurogenesis and activation of new neurons in response to spatial learning and memory","volume":"38","author":"Chow","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2025.03.009_b0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbi.2018.03.004","article-title":"Complement component 3a receptor deficiency attenuates chronic stress-induced monocyte infiltration and depressive-like behavior","volume":"70","author":"Crider","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.03.009_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.649144","article-title":"Th17 Cells in depression: are they crucial for the antidepressant effect of ketamine?","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2025.03.009_b0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yhbeh.2017.06.007","article-title":"Maternal thyroid hormone trajectories during pregnancy and child behavioral problems","volume":"94","author":"Endendijk","year":"2017","journal-title":"Horm. Behav."},{"key":"10.1016\/j.bbi.2025.03.009_b0050","first-page":"1605","article-title":"Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity","volume":"10","author":"Fan","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbi.2025.03.009_b0055","doi-asserted-by":"crossref","unstructured":"Feder, A., Parides, M.K., Murrough, J.W., Perez, A.M., Morgan, J.E., Saxena, S., Kirkwood, K., aan het Rot, M., Lapidus, K.A., Wan, L.B., Iosifescu, D.V., Charney, D.S., 2014. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71, 681-688.","DOI":"10.1001\/jamapsychiatry.2014.62"},{"key":"10.1016\/j.bbi.2025.03.009_b0060","unstructured":"First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B., 2002. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I\/P). Biometrics Research, New York State Psychiatric Institute, New York."},{"key":"10.1016\/j.bbi.2025.03.009_b0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neubiorev.2015.03.005","article-title":"The role of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?","volume":"52","author":"Freudenberg","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2025.03.009_b0070","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41386-020-00867-6","article-title":"Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia","volume":"46","author":"Gallego","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 6","key":"10.1016\/j.bbi.2025.03.009_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4088\/JCP.8133su1c.02","article-title":"Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities","volume":"70","author":"Gaynes","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0080","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1038\/s41467-022-33797-6","article-title":"Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia","volume":"13","author":"Gracias","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2025.03.009_b0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/jpm11020155","article-title":"Treatment-resistant depression revisited: a glimmer of hope","volume":"11","author":"Halaris","year":"2021","journal-title":"J. Pers. Med."},{"issue":"10","key":"10.1016\/j.bbi.2025.03.009_b0090","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fphar.2019.01302","article-title":"Ketamine and active ketamine metabolites regulate STAT3 and the type I interferon pathway in human microglia: molecular mechanisms linked to the antidepressant effects of ketamine","volume":"5","author":"Ho","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2025.03.009_b0095","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41380-023-02043-w","article-title":"The synaptic hypothesis of schizophrenia version III: a master mechanism","volume":"28","author":"Howes","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40620-020-00708-1","article-title":"Anaphylatoxins enhance Th9 cell recruitment via the CCL20-CCR6 axis in IgA nephropathy","volume":"33","author":"Hu","year":"2020","journal-title":"J. Nephrol."},{"key":"10.1016\/j.bbi.2025.03.009_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41386-023-01632-1","article-title":"Ketamine in neuropsychiatric disorders: an update","volume":"49","author":"Johnston","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2025.03.009_b0110","series-title":"Design and analysis of cross-over trials","author":"Jones","year":"2014"},{"key":"10.1016\/j.bbi.2025.03.009_b0115","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00282-24","article-title":"Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques","volume":"15","author":"Kelkar","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.bbi.2025.03.009_b0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.physbeh.2013.12.002","article-title":"Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner","volume":"126","author":"Kelly","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbi.2025.03.009_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110183","article-title":"Estrogen promotes innate immune evasion of Candida albicans through inactivation of the alternative complement system","volume":"38","author":"Kumwenda","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbi.2025.03.009_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.bbi.2025.03.009_b0135","doi-asserted-by":"crossref","first-page":"e851","DOI":"10.1038\/tp.2016.115","article-title":"Serum proteomic profiles of depressive subtypes","volume":"6","author":"Lamers","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0140","doi-asserted-by":"crossref","unstructured":"Lombardo, G., Mondelli, V., Worrell, C., Sforzini, L., Mariani, N., Nikkheslat, N., Nettis, M.A., Kose, M., Zajkowska, Z., Cattaneo, A., Pointon, L., Turner, L., Cowen, P.J., Drevets, W.C., Cavanagh, J., Harrison, N.A., Bullmore, E.T., Neuroimmunology of Mood Disorders and Alzheimer\u2019s Disease (NIMA) Consortium, Dazzan, P., Pariante, C.M., 2024. Disturbed sex hormones milieu in males and females with major depressive disorder and low-grade inflammation. J Affect Disord 356, 167-176.","DOI":"10.1016\/j.jad.2024.03.018"},{"key":"10.1016\/j.bbi.2025.03.009_b0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13293-024-00589-0","article-title":"Nrf2 activation rescues stress-induced depression-like behaviour and inflammatory responses in male but not female rats","volume":"15","author":"McCallum","year":"2024","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.bbi.2025.03.009_b0155","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/nu14050917","article-title":"Emerging evidence for the widespread role of glutamatergic dysfunction in neuropsychiatric diseases","volume":"14","author":"McGrath","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2025.03.009_b0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0165","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/0964704X.2011.623917","article-title":"Monoamine theories of depression: historical impact on biomedical research","volume":"21","author":"Mulinari","year":"2012","journal-title":"J. Hist. Neurosci."},{"key":"10.1016\/j.bbi.2025.03.009_b0170","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2025.03.009_b0175","article-title":"Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency","volume":"18","author":"Nikkheslat","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbi.2025.03.009_b0180","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0185","doi-asserted-by":"crossref","unstructured":"Ornellas, P., de M Ribeiro-Carvalho, M., Ornellas, A.A., Scherrer, L., Koifman, L., Magni, F., Ornellas, M.H., Alves, G., 2017. Experimental validation of the complement protein C3a down expression in the plasma of patients with squamous cell carcinoma of the penis. Urol Oncol 35, 545.e513-545.e518.","DOI":"10.1016\/j.urolonc.2017.05.002"},{"key":"10.1016\/j.bbi.2025.03.009_b0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neubiorev.2019.04.010","article-title":"Stress, epigenetics and depression: a systematic review","volume":"102","author":"Park","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2025.03.009_b0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2019.100007","article-title":"Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder","volume":"1","author":"Pillai","year":"2019","journal-title":"Biomark Neuropsychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0205","doi-asserted-by":"crossref","unstructured":"Quintanilla, B., Zarate, C.A., Jr., Pillai, A., 2024. Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects? Mol Psychiatry Apr 4 [online ahead of print].","DOI":"10.1038\/s41380-024-02507-7"},{"key":"10.1016\/j.bbi.2025.03.009_b0210","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: a novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bbi.2025.03.009_b0215","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fpsyt.2018.00614","article-title":"Assessment of complement cascade components in patients with bipolar disorder","volume":"9","author":"Reginia","year":"2018","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2025.03.009_b0220","article-title":"Neuroinflammation and neuroprogression in depression: effects of alternative drug treatments","volume":"26","author":"Richardson","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbi.2025.03.009_b0225","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0230","first-page":"627","article-title":"STAR*D: revising conventional wisdom","volume":"23","author":"Rush","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbi.2025.03.009_b0235","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression","volume":"62","author":"Sackeim","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.12.018","article-title":"The international study to predict optimized treatment in depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment","volume":"61","author":"Saveanu","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2025.03.009_b0245","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2025.03.009_b0250","doi-asserted-by":"crossref","unstructured":"Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., Genovese, G., Rose, S.A., Handsaker, R.E., Schizophrenia Working Group of the Psychiatric Genomics Consortium, Daly, M.J., Carroll, M.C., Stevens, B., McCarroll, S.A., 2016. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177-183.","DOI":"10.1038\/nature16549"},{"key":"10.1016\/j.bbi.2025.03.009_b0255","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41380-021-01381-x","article-title":"A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials","volume":"27","author":"Sforzini","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0260","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/stem.225","article-title":"Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells","volume":"27","author":"Shinjyo","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbi.2025.03.009_b0265","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-0327(94)90135-X","article-title":"Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls","volume":"30","author":"Song","year":"1994","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2025.03.009_b0270","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2025.03.009_b0275","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1061274","article-title":"Antidepressant effect of ketamine on inflammation-mediated cytokine dysregulation in adults with treatment-resistant depression: rapid systematicr eview","volume":"2022","author":"Sukhram","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbi.2025.03.009_b0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/03009734.2015.1060281","article-title":"The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus","volume":"120","author":"Wang","year":"2015","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.bbi.2025.03.009_b0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/NDT.S151238","article-title":"Plasma complement component 4 increases in patients with major depressive disorder","volume":"14","author":"Wei","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2025.03.009_b0290","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0295","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0300","series-title":"Depression and Other Common Mental Health Estimates: Global Health Estimates","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.bbi.2025.03.009_b0305","unstructured":"World Health Organization, 2023. Fact Sheet: Suicide (available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/suicide)."},{"key":"10.1016\/j.bbi.2025.03.009_b0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnen\/nlac035","article-title":"Ketamine regulates the autophagy flux and polarization of microglia through the HMGB1-RAGE axis and exerts antidepressant effects in mice","volume":"81","author":"Wu","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbi.2025.03.009_b0315","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/psychiatry.IndianJPsychiatry_394_19","article-title":"Is serum complement C1q related to major depressive disorder?","volume":"62","author":"Yang","year":"2020","journal-title":"Indian J. Psychiatry."},{"key":"10.1016\/j.bbi.2025.03.009_b0320","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","article-title":"Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression","volume":"77","author":"Yang","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0325","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.4049\/jimmunol.171.5.2734","article-title":"Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index","volume":"171","author":"Yang","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2025.03.009_b0330","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00213-020-05490-3","article-title":"Ketamine relieves depression-like behaviors induced by chronic postsurgical pain in rats through anti-inflammatory, anti-oxidant effects and regulating BDNF expression","volume":"237","author":"Yang","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2025.03.009_b0335","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00213-015-3919-9","article-title":"Low-grade inflammation predicts persistence of depressive symptoms","volume":"233","author":"Zalli","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2025.03.009_b0340","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2025.03.009_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173228","article-title":"Opioid receptor system contributes to the acute and sustained antidepressant-like effects, but not the hyperactivity motor effects of ketamine in mice","volume":"208","author":"Zhang","year":"2021","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.bbi.2025.03.009_b0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10565-024-09981-3","article-title":"Proteomic patterns associated with ketamine response in major depressive disorders","volume":"41","author":"Zhou","year":"2025","journal-title":"Cell Biol. Toxicol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:41:18Z","timestamp":1762314078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":70,"alternative-id":["S0889159125000960"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.03.009","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of complement cascade components in patients with major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}